You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 154 No. 11, 13 June 1994 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Investigations
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (47)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Increasing Incidence of Cancer of the Prostate

The Experience of Black and White Men in the Detroit Metropolitan Area

Raymond Y. Demers, MD, MPH; G. Marie Swanson, PhD, MPH; Linda K. Weiss, PhD; Tsing-Ying Kau, MPH

Arch Intern Med. 1994;154(11):1211-1216.


Abstract



Background
Prostate cancer mortality and incidence rates have been gradually increasing for decades in the United States, with an accelerated increase in incidence noted in the past several years. This study explores in detail the occurrence of prostate cancer in southeast Michigan from 1973 through 1991.

Methods
Data from the National Cancer Institute Surveillance, Epidemiology, and End Results program are analyzed with emphasis on time trends by race, age, stage, and treatment.

Results
Population-based rates for prostate cancer increased by 70% between 1988 and 1991. Increases are most pronounced for early stage disease and among whites compared with blacks. Corresponding increases in treatment with radical prostatectomy are also observed.

Conclusion
Increased incidence of prostate cancer is likely a result of widespread use of prostate-specific antigen.

(Arch Intern Med. 1994;154:1211-1216)



Author Affiliations



From the Division of Epidemiology, Michigan Cancer Foundation, Detroit (Drs Demers, Weiss, and Ms Kau), and the Comprehensive Breast Cancer Center, Michigan State University, East Lansing (Dr Swanson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effectiveness of Interventions for Reducing the Frequency of Radical Prostatectomy Procedures in the Elderly: An Evaluation
Sheikh and Bullock
American Journal of Medical Quality 2003;18:97-103.
ABSTRACT  

Racial and Ethnic Differences in Advanced-Stage Prostate Cancer: the Prostate Cancer Outcomes Study
Hoffman et al.
JNCI J Natl Cancer Inst 2001;93:388-395.
ABSTRACT | FULL TEXT  

Race, Treatment, and Long-term Survival From Prostate Cancer in an Equal-Access Medical Care Delivery System
Optenberg et al.
JAMA 1995;274:1599-1605.
ABSTRACT  

Incidence of Prostate Cancer Diagnosis in the Eras Before and After Serum Prostate-Specific Antigen Testing
Jacobsen et al.
JAMA 1995;274:1445-1449.
ABSTRACT  

The Role of Increasing Detection in the Rising Incidence of Prostate Cancer
Potosky et al.
JAMA 1995;273:548-552.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.